Topline Results of a Phase 2 Study of Subcutaneous IMVT-1401 in Patients with Generalized Myasthenia Gravis

被引:0
|
作者
Benatar, Michael [1 ]
Breiner, Ari [2 ]
Bril, Vera [3 ]
Nowak, Richard [4 ]
Dunn, Imogene [5 ]
Jacobs, Alan [5 ]
机构
[1] Univ Miami, Coral Gables, FL 33124 USA
[2] Ottawa Hosp, Civ Campus, Ottawa, ON, Canada
[3] Toronto Gen Hosp, Toronto, ON, Canada
[4] Yale Univ, Sch Med, New Haven, CT 06520 USA
[5] Immunovant Inc, New York, NY USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1417
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Dose Selection and Clinical Development of Efgartigimod PH20 Subcutaneous in Patients with Generalized Myasthenia Gravis
    Li, George
    Li, Yuebing
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Van Hoorick, Benjamin
    Podhorna, Jana
    Casey, Jenna
    Noukens, Jan
    Van Bragt, Tonke
    Utsugisawa, Kimiaki
    Wiendl, Heinz
    De Bleecker, Jan
    Mantegazza, Renato
    Howard, James
    NEUROLOGY, 2023, 100 (17)
  • [22] DOSE SELECTION AND CLINICAL DEVELOPMENT OF EFGARTIGIMOD PH20 SUBCUTANEOUS IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Guptill, Jeffrey
    Li, Yuebing
    Vu, Tuan
    Korobko, Denis
    Liu, Li
    Steeland, Sophie
    Van Hoorick, Benjamin
    Podhorna, Jana
    Brauer, Eddie
    Noukens, Jan
    Van Bragt, Tonke
    Utsugisawa, Kimiaki
    De Bleecker, Jan L.
    Howard, James
    MUSCLE & NERVE, 2024, 70 (03) : 705 - 705
  • [23] Phase 2 Trial of Rituximab in Myasthenia Gravis: Study Update
    Nowak, Richard J.
    Coffey, Christoper
    Goldstein, Jonathan M.
    Dimachkie, Mazen
    Benatar, Michael
    O'Connor, Kevin C.
    Kissel, John
    Hafler, David A.
    Barohn, Richard
    Cudkowicz, Merit E.
    ANNALS OF NEUROLOGY, 2015, 78 : S109 - S109
  • [24] Additional Analyses of the Phase 2 Efgartigimod Study in Myasthenia Gravis
    Howard, James
    Bril, Vera
    Mantegazza, Renato
    Beydoun, Said
    De Rivera Garrido, Fancisco Javier
    Piehl, Fredrik
    Rottoli, Maria Rosa
    Van Damme, Philip
    Vu, Tuan
    Ulrichts, Peter
    Guglietta, Antonio
    Beauchamp, Jon
    de Haard, Hans
    Verschuuren, Jan
    NEUROLOGY, 2020, 94 (15)
  • [25] Eculizumab improves fatigue in patients with refractory generalized myasthenia gravis in the REGAIN study
    Andersen, H.
    Mantegazza, R.
    Derosier, F.
    Wang, J. J.
    Zhang, J.
    Howard, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 498 - 498
  • [26] Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study
    Brandsema, John F.
    Ginsberg, Matthew
    Hoshino, Hideki
    Mimaki, Masakazu
    Nagata, Satoru
    Rao, Vamshi K.
    Ruzhansky, Katherine
    Suresh, Niraja
    Tiongson, Emmanuelle
    Yamanouchi, Hideo
    Frick, Glen
    Hicks, Eden
    Liao, Serena
    Howard, James F.
    PEDIATRIC NEUROLOGY, 2024, 156 : 198 - 207
  • [27] EFFICACY AND SAFETY OF TOLEBRUTINIB IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS: PHASE 3 STUDY DESIGN
    Barnett, Carolina
    Nicholson, Katharine
    Chen, Yixin
    Syed, Sana
    Turner, Timothy
    Smyth, Brendan
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 66 : S127 - S128
  • [28] EFFICACY AND SAFETY OF TOLEBRUTINIB IN ADULTS WITH GENERALIZED MYASTHENIA GRAVIS: PHASE 3 STUDY DESIGN
    Barnett, Carolina
    Kaminski, Henry
    Benoit, Patrick
    Chen, Yixin
    Syed, Sana
    Turner, Timothy
    Smyth, Brendan
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 66 : S47 - S48
  • [29] A PILOT TRIAL TO ASSESS THE FEASIBILITY AND EFFICACY OF SUBCUTANEOUS IMMUNOGLOBULIN IN PATIENTS WITH MYASTHENIA GRAVIS EXACERBATION - PRELIMINARY RESULTS
    Siddiqi, Z. A.
    Mallon, A.
    Blackmore, D.
    MUSCLE & NERVE, 2015, 52 : S144 - S144
  • [30] Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis The BeatMG Study
    Nowak, Richard J.
    Coffey, Christopher S.
    Goldstein, Jonathan M.
    Dimachkie, Mazen M.
    Benatar, Michael
    Kissel, John T.
    Wolfe, Gil, I
    Burns, Ted M.
    Freimer, Miriam L.
    Nations, Sharon
    Granit, Volkan
    Smith, A. Gordon
    Richman, David P.
    Ciafaloni, Emma
    Al-Lozi, Muhammad T.
    Sams, Laura Ann
    Quan, Dianna
    Ubogu, Eroboghene
    Pearson, Brenda
    Sharma, Aditi
    Yankey, Jon W.
    Uribe, Liz
    Shy, Michael
    Amato, Anthony A.
    Conwit, Robin
    O'Connor, Kevin C.
    Hafler, David A.
    Cudkowicz, Merit E.
    Barohn, Richard J.
    NEUROLOGY, 2022, 98 (04) : E376 - E389